52 results
Page 2 of 3
PREC14A
vjqpeyw
23 Nov 22
Preliminary proxy with contested solicitation
11:26am
PREC14A
jgqc1ytp
18 Nov 22
Preliminary proxy with contested solicitation
5:08pm
8-K
EX-99.1
7hkgcou njizi
18 Nov 22
Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process
4:40pm
DEFA14A
EX-99.1
3iq55u7s
14 Nov 22
Additional proxy soliciting materials
7:41am
8-K
EX-99.1
yq354c9mmijc9yg2u
14 Nov 22
Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process
7:40am
8-K
EX-99.1
ila gni826x
27 Oct 22
Diffusion Pharmaceuticals Announces Strategic Review Process to Evaluate Value-Enhancing Alternatives including Opportunities to Better Leverage TSC
4:15pm
8-K
EX-99.1
tr1qjhhk 81g
23 May 22
Diffusion Pharmaceuticals Announces Appointment of Raven Jaeger, M.S., as Chief Regulatory Officer
5:42pm
8-K
EX-99.1
lt828
13 Sep 21
Diffusion Pharmaceuticals Issues Letter to Shareholders
4:09pm